Reviva Pharmaceuticals
RVPH
RVPH
12 hedge funds and large institutions have $10.5M invested in Reviva Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$108K |
2 |
Bank of America
Charlotte,
North Carolina
|
+$101K |
3 |
BlackRock
New York
|
+$61.6K |
4 |
HF
HRT Financial
New York
|
+$54K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$37.6K |
Top Sellers
1 |
AC
Armistice Capital
New York
|
-$342K |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$83.1K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$61K |
4 |
Renaissance Technologies
New York
|
-$55K |
5 |
DC
Davenport & Co
Richmond,
Virginia
|
-$49K |